Resistance to multiple novel antifolates is mediated via defective drug transport resulting from clustered mutations in the reduced folate carrier gene in human leukaemia cell lines.

Ähnliche Einträge

• The Reduced Folate Carrier (RFC) Is Cytotoxic to Cells under Conditions of Severe Folate Deprivation: RFC AS A DOUBLE EDGED SWORD IN FOLATE HOMEOSTASIS
  von: Ifergan, Ilan, et al.
  Veröffentlicht: (2008)
• The Proton-Coupled Folate Transporter: Impact on Pemetrexed Transport and on Antifolates Activities Compared to the Reduced Folate Carrier
  von: Zhao, Rongbao, et al.
  Veröffentlicht: (2008)
• Confocal microscopy visualization of antifolate uptake by the reduced folate carrier in human leukaemic cells.
  von: Jolivet, J., et al.
  Veröffentlicht: (1997)
• Functional Loss of the Reduced Folate Carrier Enhances the Antitumor Activities of Novel Antifolates with Selective Uptake by the Proton-Coupled Folate Transporter
  von: Desmoulin, Sita Kugel, et al.
  Veröffentlicht: (2012)
• Augmentation of Reduced Folate Carrier-Mediated Folate/Antifolate Transport through an Antiport Mechanism with 5-Aminoimidazole-4-Carboxamide Riboside Monophosphate
  von: Visentin, Michele, et al.
  Veröffentlicht: (2012)